Dimensional Fund Advisors LP Boosts Stock Holdings in Bausch Health Companies Inc. (NYSE:BHC)

Dimensional Fund Advisors LP boosted its stake in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 3.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,113,107 shares of the company's stock after acquiring an additional 90,166 shares during the quarter. Dimensional Fund Advisors LP owned 0.86% of Bausch Health Companies worth $25,089,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of BHC. Vanguard Group Inc. lifted its stake in Bausch Health Companies by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 11,684,859 shares of the company's stock worth $94,460,000 after acquiring an additional 145,078 shares in the last quarter. Franklin Resources Inc. lifted its holdings in Bausch Health Companies by 1.1% during the 4th quarter. Franklin Resources Inc. now owns 5,316,822 shares of the company's stock worth $42,855,000 after buying an additional 56,446 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Bausch Health Companies by 46.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,770,793 shares of the company's stock valued at $38,501,000 after purchasing an additional 1,510,445 shares in the last quarter. SG Americas Securities LLC raised its stake in Bausch Health Companies by 62.0% during the 4th quarter. SG Americas Securities LLC now owns 3,301,981 shares of the company's stock worth $26,614,000 after acquiring an additional 1,263,706 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Bausch Health Companies by 1.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,284,036 shares of the company's stock valued at $10,375,000 after purchasing an additional 14,558 shares during the period. 78.65% of the stock is owned by institutional investors and hedge funds.

Bausch Health Companies Trading Down 3.2 %

Shares of NYSE:BHC traded down $0.15 on Friday, reaching $4.55. 1,724,544 shares of the company were exchanged, compared to its average volume of 2,630,663. Bausch Health Companies Inc. has a 1-year low of $3.96 and a 1-year high of $9.85. The company has a 50-day moving average of $5.79 and a 200-day moving average of $7.10. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of -37.91, a price-to-earnings-growth ratio of 0.37 and a beta of 0.34.

Bausch Health Companies (NYSE:BHC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.44). Bausch Health Companies had a negative return on equity of 577.82% and a negative net margin of 0.48%. The firm had revenue of $2.56 billion for the quarter, compared to analysts' expectations of $2.51 billion. As a group, analysts forecast that Bausch Health Companies Inc. will post 4.41 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Royal Bank of Canada upped their price target on shares of Bausch Health Companies from $8.50 to $10.00 and gave the company a "sector perform" rating in a research report on Friday, May 2nd. Jefferies Financial Group reissued a "hold" rating and set a $8.00 price target (down previously from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th. Finally, StockNews.com downgraded Bausch Health Companies from a "buy" rating to a "hold" rating in a research note on Saturday. One equities research analyst has rated the stock with a sell rating and seven have given a hold rating to the company's stock. Based on data from MarketBeat.com, Bausch Health Companies has an average rating of "Hold" and an average target price of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.